AAAAAA

   
Results: 1-13 |
Results: 13
The growth hormone (GH)-insulin-like growth factor axis during testosterone replacement therapy in GH-treated hypopituitary males
Authors: Fisker, S Norrelund, H Juul, A Skakkebaek, NE Christiansen, JS Jorgensen, JOL
Citation: S. Fisker et al., The growth hormone (GH)-insulin-like growth factor axis during testosterone replacement therapy in GH-treated hypopituitary males, GROWTH H I, 11(2), 2001, pp. 104-109
Continuation of growth hormone (GH) substitution during fasting in GH-deficient patients decreases urea excretion and conserves protein synthesis
Authors: Norrelund, H Moller, N Nair, KS Christiansen, JS Jorgensen, JOL
Citation: H. Norrelund et al., Continuation of growth hormone (GH) substitution during fasting in GH-deficient patients decreases urea excretion and conserves protein synthesis, J CLIN END, 86(7), 2001, pp. 3120-3129
The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown
Authors: Norrelund, H Nair, KS Jorgensen, JOL Christiansen, JS Moller, N
Citation: H. Norrelund et al., The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown, DIABETES, 50(1), 2001, pp. 96-104
Evidence-based approach to growth hormone replacement therapy in adults, with special emphasis on body composition
Authors: Conceicao, FL Jorgensen, JOL Vahl, N Norrelund, H Christiansen, JS
Citation: Fl. Conceicao et al., Evidence-based approach to growth hormone replacement therapy in adults, with special emphasis on body composition, J PED END M, 13, 2000, pp. 1353-1358
Regulation of uncoupling protein (UCP) 2 and 3 in adipose and muscle tissue by fasting and growth hormone treatment in obese humans
Authors: Pedersen, SB Borglum, JD Kristensen, K Norrelund, H Otto, J Jorgensen, L Richelsen, B
Citation: Sb. Pedersen et al., Regulation of uncoupling protein (UCP) 2 and 3 in adipose and muscle tissue by fasting and growth hormone treatment in obese humans, INT J OBES, 24(8), 2000, pp. 968-975
Muscle mass and function in thyrotoxic patients before and during medical treatment - Reply
Authors: Norrelund, H Moller, N
Citation: H. Norrelund et N. Moller, Muscle mass and function in thyrotoxic patients before and during medical treatment - Reply, CLIN ENDOCR, 53(4), 2000, pp. 541-541
Effects of growth hormone administration on protein dynamics and substratemetabolism during 4 weeks of dietary restriction in obese women
Authors: Norrelund, H Borglum, J Jorgensen, JOL Richelsen, B Moller, N Nair, KS Christiansen, JS
Citation: H. Norrelund et al., Effects of growth hormone administration on protein dynamics and substratemetabolism during 4 weeks of dietary restriction in obese women, CLIN ENDOCR, 52(3), 2000, pp. 305-312
Regulation of lipoprotein lipase and hormone-sensitive lipase activity andgene espression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients
Authors: Richelsen, B Pedersen, SB Kristensen, K Borglum, JD Norrelund, H Christiansen, JS Jorgensen, JOL
Citation: B. Richelsen et al., Regulation of lipoprotein lipase and hormone-sensitive lipase activity andgene espression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients, METABOLISM, 49(7), 2000, pp. 906-911
Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: Impact on insulin sensitivity andsubstrate metabolism
Authors: Norrelund, H Vahl, N Juul, A Moller, N Alberti, KGMM Skakkebaek, NE Christiansen, JS Jorgensen, JOL
Citation: H. Norrelund et al., Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: Impact on insulin sensitivity andsubstrate metabolism, J CLIN END, 85(5), 2000, pp. 1912-1917
Evidence supporting a direct suppressive effect of growth hormone on serumIGFBP-1 levels. Experimental studies in normal, obese and GH-deficient adults
Authors: Norrelund, H Fisker, S Vahl, N Borglum, J Richelsen, B Christiansen, JS Jorgensen, JOL
Citation: H. Norrelund et al., Evidence supporting a direct suppressive effect of growth hormone on serumIGFBP-1 levels. Experimental studies in normal, obese and GH-deficient adults, GROWTH H I, 9(1), 1999, pp. 52-60
Muscle mass and function in thyrotoxic patients before and during medical treatment
Authors: Norrelund, H Hove, KY Brems-Dalgaard, E Jurik, AG Nielsen, LP Nielsen, S Nielsen, S Jorgensen, JOL Weeke, J Moller, N
Citation: H. Norrelund et al., Muscle mass and function in thyrotoxic patients before and during medical treatment, CLIN ENDOCR, 51(6), 1999, pp. 693-699
Serum leptin concentrations during short-term administration of growth hormone and triiodothyronine in healthy adults: A randomised, double-blind placebo-controlled study
Authors: Wolthers, T Lechuga, A Grofte, T Norrelund, H Moller, N Christiansen, JS Jorgensen, JOL
Citation: T. Wolthers et al., Serum leptin concentrations during short-term administration of growth hormone and triiodothyronine in healthy adults: A randomised, double-blind placebo-controlled study, HORMONE MET, 31(1), 1999, pp. 37-40
Serum leptin levels and leptin expression in growth hormone (GH)-deficientand healthy adults: Influence of GH treatment, gender, and easting
Authors: Kristensen, K Pedersen, SB Fisker, S Norrelund, H Rosenfalck, AM Jorgensen, JOL Richelsen, B
Citation: K. Kristensen et al., Serum leptin levels and leptin expression in growth hormone (GH)-deficientand healthy adults: Influence of GH treatment, gender, and easting, METABOLISM, 47(12), 1998, pp. 1514-1519
Risultati: 1-13 |